NCT04773379View on ClinicalTrials.gov

Validation of the PNQ for CIPN Patients.

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
Chemotherapy-induced Peripheral Neuropathy
Trial Locations (1)

85133

General Hospital of Rhodes, Rhodes

All Listed Sponsors
lead

Democritus University of Thrace

OTHER

NCT04773379 - Validation of the PNQ for CIPN Patients. | Biotech Hunter | Biotech Hunter